Skip to main content
SpringerLink
Log in

Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar hydatid disease

  • Original Investigations
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

In human alveolar echinococcosis radical surgery is the only curative therapy. Local recurrences after “radical” surgery have been observed rather frequently in former years. Postoperative “prophylactic” chemotherapy with benzimidazole derivatives over two years appears to prevent local recurrences according to our experience. In addition five patients of our series who suffered from primarily non-resectable alveolar echinococcosis became radically operable after an average of 2 years of chemotherapy. Our experience suggests that chemotherapy improves resectability and curability of surgery in alveolar echinococcosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AHD:

alveolar hydatid disease

SESG:

Swiss Echinococcosis Study Group

References

  • Akovbiantz A, Ammann R, Eckert J (1978) Gibt es eine Chemotherapie der Echinokokkose des Menschen? Schweiz Med Wochenschr 108:1101–1103

    Google Scholar 

  • Ammann R, Tschudi K, Ziegler M von, Meister F, Cotting J, Eckert J, Witassek F, Freiburghaus A (1988) Langzeitverlauf bei 60 Patienten mit alveolärer Echinokokkose unter Dauertherapie mit Mebendazol (1976–1985). Klin Wochenschr 66:1060–1073

    Google Scholar 

  • Ammann R, Hirsbrunner R, Cotting J, Steiger J, Jacquier P, Eckert J (1990) Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis. Am J Trop Med Hyg 43:506–515

    Google Scholar 

  • Cipeng J (1981) Liver alveolar echinococcosis in the Northwest. Report of 15 patients and a collective analysis of 90 cases. Chin Med J 94:771–778

    Google Scholar 

  • Eckert J (1986) Prospects for treatment of the metacestode stage of echinococcus. In: Thompson RCA (ed) The biology of echinococcus and hydatid disease. Allen & Unwin, London, pp 250–284

    Google Scholar 

  • Eckert J, Pohlenz J (1976) Zur Wirkung von Mebendazol auf Metazestoden vonMesocestoides corti undEchinococcus multilocularis. Tropenmed Parasitol 27:247–262

    Google Scholar 

  • Gillet M, Miguet JP, Mantion G, Bresson-Hadni S, Becker MC, Rouget C, Christophe JL, Roullier M, Landeeg G, Guarder L, Bechtel P, Vuitten D (1988) Orthotopic liver transplantation in alveolar echinococcosis of the liver. Transplant Proc 20:573–576

    Google Scholar 

  • Gottstein B, Tschudi K, Eckert J, Ammann R (1989) Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesion. Trans R Soc Trop Med Hyg 83:389–393

    Google Scholar 

  • Guest J, Blumgart LH (1987) Surgery of liver tumours. Baillière's Clin Gastroenterol 1:131–150

    Google Scholar 

  • Kasai Y, Koshino J, Kawanishi N, Sakamoto H, Sasaki E, Kumagai M (1980) Alveolar echinococcosis of the liver. Ann Surg 191:145–152

    Google Scholar 

  • Koslowski L, Bähr R, Kummer D (1979) Klinik und Therapie des Leberechinokokkus. Chirurg 50:140–145

    Google Scholar 

  • Leese T, Bismuth H (1989) Surgical management of space-occupying lesions in the liver. Baillière's Clin Gastroenterol 3:253–277

    Google Scholar 

  • Pogany AC, Kerlan RK, Ring EJ (1985) Percutaneous biliary drainage. Clin Gastroenterol 14:387–402

    Google Scholar 

  • Rauch RL, Wilson JF, McMahon BJ, O'Gorman MA (1986) Consequences of continuous mebendazole therapy in alveolar hydatid disease with a summary of a ten-year clinical trial. Ann Trop Med Parasitol 80:403–419

    Google Scholar 

  • Rausch RL, Wilson JF, Schantz PM, McMahon BJ (1987) Spontaneous death ofEchinococcus multilocularis: cases diagnosed serologically (by EM2 ELISA) and clinical significance. Am J Trop Med Hyg 36:676–685

    Google Scholar 

  • Schantz PM, Bossche H van den, Eckert J (1982) Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z Parasitendk 67:5–26

    Google Scholar 

  • Schantz PM, Gottstein B, Ammann R, Lanier A (1990) Report of a workshop on alveolar hydatid disease (Anchorage, June 1990). Parasitol Today (in press)

  • Semenov VS, Pechen OR, Papovodu P (1954) Alveolianogo eckkinokoka. Vestn Khir Grekova 74:20–26

    Google Scholar 

  • Vuitten OA, Bresson Hadni S, Liance M (1990) L'echinococcose alvéolaire humaine. Hasard epidémiologique ou fatalité immunologique? Gastroenterol Clin Biol 14:124–130

    Google Scholar 

  • Wilson JF, Rausch RL (1982) Mebendazole and alveolar hydatid disease. Ann Trop Med Parasitol 76:165–173

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gastroenterology Division, Department of Internal Medicine, University Hospital, CH-8091, Zurich, Switzerland

    Rudolf W. Ammann

Authors
  1. Rudolf W. Ammann
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Swiss Echinococcosis Study Group (SESG)

Additional information

Dedicated to Prof. Dr. J. Eckert, Director of the Institute of Parasitology, University of Zurich, on the occasion of his 60th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ammann, R.W., Swiss Echinococcosis Study Group (SESG). Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar hydatid disease. Parasitol Res 77, 290–293 (1991). https://doi.org/10.1007/BF00930903

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00930903

Keywords

Search

Navigation